POP MART
09992
XIAOMI-W
01810
MEITUAN-W
03690
4
BABA-W
09988
5
HORIZONROBOT-W
09660
HK Stock MarketDetailed Quotes
01244 3D MEDICINES
- 3.430
- -0.050-1.44%
Not Open Apr 29 16:08 CST
885.55MMarket Cap-4.49P/E (TTM)
3.500High3.310Low166.00KVolume3.310Open3.480Pre Close569.37KTurnover0.06%Turnover RatioLossP/E (Static)258.18MShares8.38052wk High1.04P/B885.55MFloat Cap1.60052wk Low--Dividend TTM258.18MShs Float131.500Historical High--Dividend LFY5.46%Amplitude1.600Historical Low3.429Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
3D MEDICINES Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | -29.81%445.65M | -41.45%206.42M | 11.91%634.95M | --352.55M | 841.57%567.39M | --60.26M | ---- | ---- |
| Operating income | -29.81%445.65M | -41.45%206.42M | 11.91%634.95M | 352.55M | 841.57%567.39M | 60.26M | ||
| Cost of sales | 25.50%-36.57M | 36.00%-17.47M | -16.29%-49.09M | ---27.3M | -887.02%-42.22M | ---4.28M | ---- | ---- |
| Operating expenses | 25.50%-36.57M | 36.00%-17.47M | -16.29%-49.09M | -27.3M | -887.02%-42.22M | -4.28M | ||
| Gross profit | -30.18%409.08M | -41.91%188.95M | 11.55%585.86M | 325.25M | 838.10%525.18M | 55.98M | ||
| Selling expenses | 37.72%-235.94M | 50.18%-110.08M | -5.91%-378.81M | ---220.97M | -734.99%-357.66M | ---42.83M | ---- | ---- |
| Administrative expenses | 63.95%-78.26M | 44.49%-43.5M | -51.98%-217.08M | ---78.37M | 5.38%-142.83M | -272.47%-150.96M | 1.37%-40.53M | ---41.09M |
| Research and development expenses | 57.53%-180.72M | 43.74%-85.29M | -21.27%-425.5M | ---151.61M | 5.47%-350.86M | -40.61%-371.16M | -15.07%-263.97M | ---229.39M |
| Revaluation surplus | ---- | ---- | ---- | ---- | 31.17%-657.16M | -199.07%-954.74M | -23,830.43%-319.23M | ---1.33M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | 31.17%-657.16M | -199.07%-954.74M | -23,830.43%-319.23M | ---1.33M |
| Impairment and provision | -1,301.55%-10.06M | -1,622.38%-4.77M | 171.23%837K | ---277K | -803.85%-1.18M | ---130K | ---- | ---- |
| -Other impairment is provision | -1,301.55%-10.06M | -1,622.38%-4.77M | 171.23%837K | ---277K | -803.85%-1.18M | ---130K | ---- | ---- |
| Special items of operating profit | 21.69%-93.98M | 9.77%-54.32M | -86.31%-120.01M | ---60.19M | -1,917.47%-64.41M | 198.66%3.54M | 89.25%-3.59M | ---33.41M |
| Operating profit | 65.77%-189.88M | 41.44%-109.01M | 47.12%-554.69M | -186.16M | 28.17%-1.05B | -132.78%-1.46B | -105.53%-627.32M | -305.23M |
| Financing cost | -22.27%-9.5M | -25.23%-5.06M | -149.66%-7.77M | ---4.04M | -103.73%-3.11M | 81.04%-1.53M | 47.01%-8.06M | ---15.21M |
| Earning before tax | 64.55%-199.38M | 40.03%-114.07M | 46.54%-562.47M | -190.2M | 28.03%-1.05B | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Tax | ---- | ---- | ---55K | ---- | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 64.56%-199.38M | 40.03%-114.07M | 46.53%-562.52M | -190.2M | 28.03%-1.05B | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Earning after tax | 64.56%-199.38M | 40.03%-114.07M | 46.53%-562.52M | -190.2M | 28.03%-1.05B | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Minority profit | 55.81%-16.72M | 9.85%-10.57M | -36.65%-37.82M | ---11.72M | 0.19%-27.68M | ---27.73M | ---- | ---- |
| Profit attributable to shareholders | 65.19%-182.66M | 42.01%-103.51M | 48.78%-524.7M | -178.49M | 28.57%-1.02B | -125.71%-1.43B | -98.29%-635.38M | -320.43M |
| Basic earnings per share | 67.39%-0.75 | 46.84%-0.42 | 89.79%-2.3 | -0.79 | 38.67%-22.52 | -163.60%-36.72 | -34.20%-13.93 | -10.38 |
| Diluted earnings per share | 67.39%-0.75 | 46.84%-0.42 | 89.79%-2.3 | -0.79 | 38.67%-22.52 | -163.60%-36.72 | -34.20%-13.93 | -10.38 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.